|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Figure 51-8
Sequential sufentanil clearance during the first month
of life in three neonates with congenital heart disease. Clearance of sufentanil
increases above adult rates within the neonatal period. (Data from Greeley
WJ, de Bruijn NP: Changes in sufentanil pharmacokinetics within the neonatal period.
Anesth Analg 67:86, 1988.)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
